Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
In March 2026, Medtronic’s MiniMed went public to advance wearable insulin pumps amid rising diabetes rates and market growth.
The global pen needles market is projected to grow from $3.5 billion in 2023 to $8.5 billion by 2031, driven by rising diabetes rates, home healthcare adoption, and innovations like ultra-fine, shorter needles and smart device compatibility.
Meanwhile, the insulin syringes market is expected to rise from $1.56 billion in 2020 to $2.40 billion by 2030, supported by diabetes prevalence and improved access.
In March 2026, Medtronic’s MiniMed division went public to fund next-gen wearable insulin delivery systems, while Insulet and Modular Medical advanced their automated and low-cost patch pumps.
Disposable insulin pumps are growing rapidly, with open-loop systems dominating the U.S. market, and North America leading globally due to innovation and infrastructure.
En marzo de 2026, el MiniMed de Medtronic se hizo público para avanzar en las bombas de insulina portátiles en medio del aumento de las tasas de diabetes y el crecimiento del mercado.